Iron Metabolism and Anemia in Chronic Kidney Disease

A major global health issue, chronic kidney disease (CKD) affects millions of people worldwide. Anaemia, which is characterised by a lower than normal red blood cell count and reduced haemoglobin levels, is one of the most common consequences of CKD. It takes a thorough knowledge of the complex and diverse link between iron metabolism, inflammation, and anaemia in CKD for effective therapies to be developed that not only address iron shortage but also improve erythropoiesis and treat anaemia in CKD patients.